EDITORIAL SECTION

  • STRATEGY

    Smarter Pharma

    Quality management systems QMS are the backbone of pharmaceutical manufacturing ensuring safe products

  • EXPERT Talk

    Compliance to Competitive Advantage in Pharma Supply

    Compliance gets you through an audit Resilience gets medicines to patients on the day something unexpected happens The DSCSAs enhanced requirements took effect November but real interoperability required three more rounds of accommodation phased implementation with the smalldispenser

KNOWLEDGE BANK

  • Articles

    Generative AI in Pharma: Scaling Productivity without Compromising

    Most enterprise technologies enter a pharmaceutical company through a single door A manufacturing execution system arrives at a site A clinical data platform arrives in development Governance follows the deployment because there is a deployment to govern Generative AI did not behave this way It reached medical writers regulatory managers safety officers market access teams and commercial staff sim...

    10 Effective Strategies to Reduce Water Waste in Pharmaceutical Manufacturing

    Water is a resource of great concern to pharmaceutical manufacturing since it is essential in the cleaning of equipment used in manufacturing operations as well as in drug formulations Nevertheless the pharmaceutical industry presents another leading water consumer and therefore reduction of water wastes should be at the top of the agenda regarding sustainability

    Fundamentals of Clinical Pharmacology: Understanding Drug Actions and Ensuring Safety

    Clinical pharmacology offers the interface between the philosophies of pharmacology and its application in the actual sense in patient care Fundamentally it is the science which examines the activities of drugs how drugs communicate with biological systems and how such communications result in treatment outcomes or adverse events Clinical pharmacology principles are needed to make sense of how m...

    10 Essential Factors for Selecting a Pharma Publisher in Europe

    European pharmaceutical industry is one of the most progressive professional and productive industries in the world As it is understood researchers aspiring to publish novel papers are interested in credible pharma publishers Selecting appropriate publisher increases the visibility of your work and contributes to societal benefit but choosing wrong publisher decreases the value of your work This g...

    The Role of Technology in Drug Anti-Counterfeiting Efforts

    With the rise of drug counterfeiting posing a serious threat to global public health the role of technology in anticounterfeiting efforts has become increasingly vital As counterfeit drugs continue to infiltrate the market

    Mini-Tablets: A Valid Strategy to Combine Efficacy and Safety in Pediatrics

    People respond very differently to medications depending on their weight age inborn capability to metabolize drugs the individual characteristics of the disease or the presence of comorbidities The wellknown assumption that one size fits all has clearly revealed all its limitations and become questionable Notably among humans pediatric patients represent

TOP ARTICLES

  • 5

    Mini-Tablets: A Valid Strategy to Combine Efficacy and Safety in Pediatrics

    Guendalina Zuccari

    Silvana Alfei

    Danilo Marimpietri

    Valentina Iurilli

    Paola Barabino

    Leonardo Marchitto

    In the treatment of pediatric diseases, mass-produced dosage forms are often not suitable for children. Commercially available medicines are commonly manipulated and mixed with food by caregivers at h...

press releases Read more...

Ionis partner Novartis announces Lp(a)HORIZON Phase 3 topline results for pelacarsen in patients with elevated Lp(a) and established cardiovascular disease (CVD)

Ionis Pharmaceuticals Inc Nasdaq IONS partner Novartis today announced that the pelacarsen Phase LpaHORIZON study a pioneering cardiovascular outcomes trial did not meet its primary endpoint

Novartis announces Lp(a)HORIZON Phase III topline results for pelacarsen in patients with elevated Lp(a) and established cardiovascular disease (CVD)

Novartis today announced that the pelacarsen phase III LpaHORIZON trial a pioneering cardiovascular outcomes study did not meet its primary endpoint of reducing the risk of cardiovascular events a composite

Climb Bio Announces CLYM116 Phase 1 Data Demonstrating Prolonged Half-Life and Best-In-Class APRIL Suppression Supporting Every-12-Week Dosing in IgA Nephropathy

Climb Bio Inc Nasdaq CLYM a clinicalstage biotechnology company developing therapeutics for patients with immunemediated diseases today announced positive initial data from the ongoing

Applied Biologics Achieves Key Preclinical Milestone in Disease-Modifying Osteoarthritis Gene Therapy Program

Applied Biologics a biopharmaceutical company advancing novel therapies for serious diseases with significant unmet medical needs today announced an important preclinical milestone in its DiseaseModifying

03 - 05

Sep 2026

5th MENA Congress for Rare Diseases 2026

Beach Rotana Hotel, Abu Dhabi,...

14 - 15

Sep 2026

16th American DDF Summit

Omni Boston Hotel at the Seapo...

15 - 17

Sep 2026

COPD Drug Development Summit 2026

Street, Boston, MA 02210, USA

21 - 23

Sep 2026

21 - 23

Sep 2026

Cancer R&D World Conference

Hilton Garden Inn Miami Dolphi...

22 - 23

Sep 2026

22 - 24

Sep 2026

LATEST NEWS Read more...

AtomVie opens new radiopharmaceutical manufacturing facility in Ontario

AtomVie Global Radiopharma AtomVie has opened a new purposebuilt radiopharmaceutical manufacturing facility in Hamilton Ontario strengthening its capacity to support drug development and commercial production

Acepodia receives FDA clearance for ACE723 antibody-drug conjugate

Acepodia a clinicalstage biotechnology company developing cell therapies and antibodydrug conjugates ADCs has received clearance from the US Food and Drug Administration FDA for its Investigational New Drug IND application for ACE

Kali Therapeutics Receives U.S. FDA Clearance for KT501 Clinical Trial

Kali Therapeutics a clinicalstage biotechnology company developing immuneresetting and multispecific therapies has received clearance from the US Food and Drug Administration FDA for its Investigational New

Abcam and Genedata Collaborate to Accelerate AI-Driven Antibody Development

Genedata has expanded its collaboration with Abcam to strengthen antibody development and support the use of artificial intelligence AI across Abcams global research and development operations

Evotec and Plectonic Enter Research Collaboration to Explore New T-Cell-Engaging Approaches for Solid Tumours

Evotec SE and Plectonic Biotech have entered a research collaboration to explore a new immunotherapy approach for solid tumours The partnership will combine Plectonics programmable LOGIBODY

NewBiologix and Synastra Biotechnology Partner to Advance Stable rAAV Manufacturing for Duchenne Muscular Dystrophy Gene Therapy

NewBiologix SA and Synastra Biotechnology Inc have entered into an agreement to develop a stable producer cell line for Synastras investigational gene therapy programme for Duchenne muscular dystrophy DMD